Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Genomic profiling in locally advanced and inflammatory breast cancer and its link to DCE-MRI and overall survival.

Siamakpour-Reihani S, Owzar K, Jiang C, Scarbrough PM, Craciunescu OI, Horton JK, Dressman HK, Blackwell KL, Dewhirst MW.

Int J Hyperthermia. 2015 Jun;31(4):386-95. doi: 10.3109/02656736.2015.1016557. Epub 2015 Mar 26.

2.

A translatable predictor of human radiation exposure.

Lucas J, Dressman HK, Suchindran S, Nakamura M, Chao NJ, Himburg H, Minor K, Phillips G, Ross J, Abedi M, Terbrueggen R, Chute JP.

PLoS One. 2014 Sep 25;9(9):e107897. doi: 10.1371/journal.pone.0107897. eCollection 2014.

3.

Retraction: Acharya CR, et al. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer. JAMA. 2008;299(13):1574-1587.

Acharya CR, Hsu DS, Anders CK, Anguiano A, Salter KH, Walters KS, Redman RC, Tuchman SA, Moylan CA, Mukherjee S, Barry WT, Dressman HK, Ginsburg GS, Marcom KP, Garman KS, Lyman GH, Nevins JR, Potti A.

JAMA. 2012 Feb 1;307(5):453. doi: 10.1001/jama.2012.2. Epub 2012 Jan 6. No abstract available.

PMID:
22228686
4.

A methodology for utilization of predictive genomic signatures in FFPE samples.

Freedman JA, Augustine CK, Selim AM, Holshausen KC, Wei Z, Tsamis KA, Hsu DS, Dressman HK, Barry WT, Tyler DS, Nevins JR.

BMC Med Genomics. 2011 Jul 11;4:58. doi: 10.1186/1755-8794-4-58.

5.

Retraction: A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer. N Engl J Med 2006;355:570-80.

Potti A, Mukherjee S, Petersen R, Dressman HK, Bild A, Koontz J, Kratzke R, Watson MA, Kelley M, Ginsburg GS, West M, Harpole DH Jr, Nevins JR.

N Engl J Med. 2011 Mar 24;364(12):1176. doi: 10.1056/NEJMc1101915. Epub 2011 Mar 2.

6.

Retraction: Genomic signatures to guide the use of chemotherapeutics.

Potti A, Dressman HK, Bild A, Riedel RF, Chan G, Sayer R, Cragun J, Cottrill H, Kelley MJ, Petersen R, Harpole D, Marks J, Berchuck A, Ginsburg GS, Febbo P, Lancaster J, Nevins JR.

Nat Med. 2011 Jan;17(1):135. doi: 10.1038/nm0111-135. No abstract available.

PMID:
21217686
7.

Diagnosis of partial body radiation exposure in mice using peripheral blood gene expression profiles.

Meadows SK, Dressman HK, Daher P, Himburg H, Russell JL, Doan P, Chao NJ, Lucas J, Nevins JR, Chute JP.

PLoS One. 2010 Jul 12;5(7):e11535. doi: 10.1371/journal.pone.0011535.

8.

Intratumor heterogeneity and precision of microarray-based predictors of breast cancer biology and clinical outcome.

Barry WT, Kernagis DN, Dressman HK, Griffis RJ, Hunter JD, Olson JA, Marks JR, Ginsburg GS, Marcom PK, Nevins JR, Geradts J, Datto MB.

J Clin Oncol. 2010 May 1;28(13):2198-206. doi: 10.1200/JCO.2009.26.7245. Epub 2010 Apr 5.

9.

Ovarian cancer tumor infiltrating T-regulatory (T(reg)) cells are associated with a metastatic phenotype.

Barnett JC, Bean SM, Whitaker RS, Kondoh E, Baba T, Fujii S, Marks JR, Dressman HK, Murphy SK, Berchuck A.

Gynecol Oncol. 2010 Mar;116(3):556-62. doi: 10.1016/j.ygyno.2009.11.020. Epub 2009 Dec 14.

PMID:
20006900
10.

Microarray analysis of early stage serous ovarian cancers shows profiles predictive of favorable outcome.

Berchuck A, Iversen ES, Luo J, Clarke JP, Horne H, Levine DA, Boyd J, Alonso MA, Secord AA, Bernardini MQ, Barnett JC, Boren T, Murphy SK, Dressman HK, Marks JR, Lancaster JM.

Clin Cancer Res. 2009 Apr 1;15(7):2448-55. doi: 10.1158/1078-0432.CCR-08-2430. Epub 2009 Mar 24.

11.

Characterizing the developmental pathways TTF-1, NKX2-8, and PAX9 in lung cancer.

Hsu DS, Acharya CR, Balakumaran BS, Riedel RF, Kim MK, Stevenson M, Tuchman S, Mukherjee S, Barry W, Dressman HK, Nevins JR, Powers S, Mu D, Potti A.

Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5312-7. doi: 10.1073/pnas.0900827106. Epub 2009 Mar 11. Erratum in: Proc Natl Acad Sci U S A. 2011 Aug 30;108(35):14705.

12.

Novel tumor sampling strategies to enable microarray gene expression signatures in breast cancer: a study to determine feasibility and reproducibility in the context of clinical care.

Tebbit CL, Zhai J, Untch BR, Ellis MJ, Dressman HK, Bentley RC, Baker JA, Marcom PK, Nevins JR, Marks JR, Olson JA Jr.

Breast Cancer Res Treat. 2009 Dec;118(3):635-43. doi: 10.1007/s10549-008-0301-1. Epub 2009 Feb 18.

13.

Failure of terminal erythroid differentiation in EKLF-deficient mice is associated with cell cycle perturbation and reduced expression of E2F2.

Pilon AM, Arcasoy MO, Dressman HK, Vayda SE, Maksimova YD, Sangerman JI, Gallagher PG, Bodine DM.

Mol Cell Biol. 2008 Dec;28(24):7394-401. doi: 10.1128/MCB.01087-08. Epub 2008 Oct 13.

14.

Unfolded protein response genes regulated by CED-1 are required for Caenorhabditis elegans innate immunity.

Haskins KA, Russell JF, Gaddis N, Dressman HK, Aballay A.

Dev Cell. 2008 Jul;15(1):87-97. doi: 10.1016/j.devcel.2008.05.006.

15.

Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer.

Acharya CR, Hsu DS, Anders CK, Anguiano A, Salter KH, Walters KS, Redman RC, Tuchman SA, Moylan CA, Mukherjee S, Barry WT, Dressman HK, Ginsburg GS, Marcom KP, Garman KS, Lyman GH, Nevins JR, Potti A.

JAMA. 2008 Apr 2;299(13):1574-87. doi: 10.1001/jama.299.13.1574. Retraction in: Acharya CR, Hsu DS, Anders CK, Anguiano A, Salter KH, Walters KS, Redman RC, Tuchman SA, Moylan CA, Mukherjee S, Barry WT, Dressman HK, Ginsburg GS, Marcom KP, Garman KS, Lyman GH, Nevins JR, Potti A. JAMA. 2012 Feb 1;307(5):453.

PMID:
18387932
16.

Gene expression signatures of radiation response are specific, durable and accurate in mice and humans.

Meadows SK, Dressman HK, Muramoto GG, Himburg H, Salter A, Wei Z, Ginsburg GS, Chao NJ, Nevins JR, Chute JP.

PLoS One. 2008 Apr 2;3(4):e1912. doi: 10.1371/journal.pone.0001912. Erratum in: PLoS ONE. 2008;3(5). doi: 10.1371/annotation/83c37842-8867-4cfb-a271-9e4bf36fb9b8. Ginsburg, Geoff [corrected to Ginsburg, Geoffrey S].

17.

An integrated approach to the prediction of chemotherapeutic response in patients with breast cancer.

Salter KH, Acharya CR, Walters KS, Redman R, Anguiano A, Garman KS, Anders CK, Mukherjee S, Dressman HK, Barry WT, Marcom KP, Olson J, Nevins JR, Potti A.

PLoS One. 2008 Apr 2;3(4):e1908. doi: 10.1371/journal.pone.0001908. Retraction in: PLoS One. 2011;6(9). doi: 10.1371/annotation/8f94e479-4161-43a0-a28c-4c0460bb89a4.

18.

Pharmacogenomic strategies provide a rational approach to the treatment of cisplatin-resistant patients with advanced cancer.

Hsu DS, Balakumaran BS, Acharya CR, Vlahovic V, Walters KS, Garman K, Anders C, Riedel RF, Lancaster J, Harpole D, Dressman HK, Nevins JR, Febbo PG, Potti A.

J Clin Oncol. 2007 Oct 1;25(28):4350-7. Retraction in: J Clin Oncol. 2010 Dec 10;28(35):5229. Erratum in: J Clin Oncol. 2010 Jun 1;28(16):2805.

PMID:
17906199
19.

Gene expression signatures that predict radiation exposure in mice and humans.

Dressman HK, Muramoto GG, Chao NJ, Meadows S, Marshall D, Ginsburg GS, Nevins JR, Chute JP.

PLoS Med. 2007 Apr;4(4):e106.

20.

An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer.

Dressman HK, Berchuck A, Chan G, Zhai J, Bild A, Sayer R, Cragun J, Clarke J, Whitaker RS, Li L, Gray J, Marks J, Ginsburg GS, Potti A, West M, Nevins JR, Lancaster JM.

J Clin Oncol. 2007 Feb 10;25(5):517-25. Retraction in: J Clin Oncol. 2012 Feb 20;30(6):678.

PMID:
17290060
21.

Genomic signatures in non-small-cell lung cancer: targeting the targeted therapies.

Dressman HK, Bild A, Garst J, Harpole D Jr, Potti A.

Curr Oncol Rep. 2006 Jul;8(4):252-7. Review.

PMID:
17254524
22.

Genomic signatures to guide the use of chemotherapeutics.

Potti A, Dressman HK, Bild A, Riedel RF, Chan G, Sayer R, Cragun J, Cottrill H, Kelley MJ, Petersen R, Harpole D, Marks J, Berchuck A, Ginsburg GS, Febbo P, Lancaster J, Nevins JR.

Nat Med. 2006 Nov;12(11):1294-300. Epub 2006 Oct 22. Erratum in: Nat Med. 2007 Nov;13(11):1388. Nat Med. 2008 Aug;14(8):889. Retraction in: Potti A, Dressman HK, Bild A, Riedel RF, Chan G, Sayer R, Cragun J, Cottrill H, Kelley MJ, Petersen R, Harpole D, Marks J, Berchuck A, Ginsburg GS, Febbo P, Lancaster J, Nevins JR. Nat Med. 2011 Jan;17(1):135.

PMID:
17057710
23.

Assessing incomplete deprotection of microarray oligonucleotides in situ.

Dressman HK, Barley-Maloney L, Rowlette LL, Agris PF, Garcia-Blanco MA.

Nucleic Acids Res. 2006;34(19):e131. Epub 2006 Oct 4.

24.

Identification of genes associated with ovarian cancer metastasis using microarray expression analysis.

Lancaster JM, Dressman HK, Clarke JP, Sayer RA, Martino MA, Cragun JM, Henriott AH, Gray J, Sutphen R, Elahi A, Whitaker RS, West M, Marks JR, Nevins JR, Berchuck A.

Int J Gynecol Cancer. 2006 Sep-Oct;16(5):1733-45.

PMID:
17009964
25.

A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.

Potti A, Mukherjee S, Petersen R, Dressman HK, Bild A, Koontz J, Kratzke R, Watson MA, Kelley M, Ginsburg GS, West M, Harpole DH Jr, Nevins JR.

N Engl J Med. 2006 Aug 10;355(6):570-80. Retraction in: Potti A, Mukherjee S, Petersen R, Dressman HK, Bild A, Koontz J, Kratzke R, Watson MA, Kelley M, Ginsburg GS, West M, Harpole DH Jr, Nevins JR. N Engl J Med. 2011 Mar 24;364(12):1176. Erratum in: N Engl J Med. 2007 Jan 11;356(2):201-2.

26.

Phase I trial of sequential low-dose 5-aza-2'-deoxycytidine plus high-dose intravenous bolus interleukin-2 in patients with melanoma or renal cell carcinoma.

Gollob JA, Sciambi CJ, Peterson BL, Richmond T, Thoreson M, Moran K, Dressman HK, Jelinek J, Issa JP.

Clin Cancer Res. 2006 Aug 1;12(15):4619-27.

27.

Toxicogenomic studies of the rat brain at an early time point following acute sarin exposure.

Damodaran TV, Greenfield ST, Patel AG, Dressman HK, Lin SK, Abou-Donia MB.

Neurochem Res. 2006 Mar;31(3):367-81. Epub 2006 May 13.

PMID:
16733813
28.

ALK1 signalling analysis identifies angiogenesis related genes and reveals disparity between TGF-beta and constitutively active receptor induced gene expression.

Lux A, Salway F, Dressman HK, Kröner-Lux G, Hafner M, Day PJ, Marchuk DA, Garland J.

BMC Cardiovasc Disord. 2006 Apr 4;6:13.

29.

Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapy.

Dressman HK, Hans C, Bild A, Olson JA, Rosen E, Marcom PK, Liotcheva VB, Jones EL, Vujaskovic Z, Marks J, Dewhirst MW, West M, Nevins JR, Blackwell K.

Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):819-26.

30.

Gene expression profiles of the rat brain both immediately and 3 months following acute sarin exposure.

Damodaran TV, Patel AG, Greenfield ST, Dressman HK, Lin SM, Abou-Donia MB.

Biochem Pharmacol. 2006 Feb 14;71(4):497-520. Epub 2005 Dec 27.

PMID:
16376859
31.

Molecular profile and partial functional analysis of novel endothelial cell-derived growth factors that regulate hematopoiesis.

Chute JP, Muramoto GG, Dressman HK, Wolfe G, Chao NJ, Lin S.

Stem Cells. 2006 May;24(5):1315-27. Epub 2005 Dec 22.

32.

Oncogenic pathway signatures in human cancers as a guide to targeted therapies.

Bild AH, Yao G, Chang JT, Wang Q, Potti A, Chasse D, Joshi MB, Harpole D, Lancaster JM, Berchuck A, Olson JA Jr, Marks JR, Dressman HK, West M, Nevins JR.

Nature. 2006 Jan 19;439(7074):353-7. Epub 2005 Nov 6.

PMID:
16273092
33.

Gene-expression patterns predict phenotypes of immune-mediated thrombosis.

Potti A, Bild A, Dressman HK, Lewis DA, Nevins JR, Ortel TL.

Blood. 2006 Feb 15;107(4):1391-6. Epub 2005 Nov 1. Retraction in: Blood. 2011 Oct 20;118(16):4497.

34.

Distinctions in the specificity of E2F function revealed by gene expression signatures.

Black EP, Hallstrom T, Dressman HK, West M, Nevins JR.

Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15948-53. Epub 2005 Oct 25.

35.

Gene expression changes and signaling events associated with the direct antimelanoma effect of IFN-gamma.

Gollob JA, Sciambi CJ, Huang Z, Dressman HK.

Cancer Res. 2005 Oct 1;65(19):8869-77.

36.

Gene expression profiling and genetic markers in glioblastoma survival.

Rich JN, Hans C, Jones B, Iversen ES, McLendon RE, Rasheed BK, Dobra A, Dressman HK, Bigner DD, Nevins JR, West M.

Cancer Res. 2005 May 15;65(10):4051-8.

37.

Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers.

Berchuck A, Iversen ES, Lancaster JM, Pittman J, Luo J, Lee P, Murphy S, Dressman HK, Febbo PG, West M, Nevins JR, Marks JR.

Clin Cancer Res. 2005 May 15;11(10):3686-96.

38.

Standardizing global gene expression analysis between laboratories and across platforms.

Bammler T, Beyer RP, Bhattacharya S, Boorman GA, Boyles A, Bradford BU, Bumgarner RE, Bushel PR, Chaturvedi K, Choi D, Cunningham ML, Deng S, Dressman HK, Fannin RD, Farin FM, Freedman JH, Fry RC, Harper A, Humble MC, Hurban P, Kavanagh TJ, Kaufmann WK, Kerr KF, Jing L, Lapidus JA, Lasarev MR, Li J, Li YJ, Lobenhofer EK, Lu X, Malek RL, Milton S, Nagalla SR, O'malley JP, Palmer VS, Pattee P, Paules RS, Perou CM, Phillips K, Qin LX, Qiu Y, Quigley SD, Rodland M, Rusyn I, Samson LD, Schwartz DA, Shi Y, Shin JL, Sieber SO, Slifer S, Speer MC, Spencer PS, Sproles DI, Swenberg JA, Suk WA, Sullivan RC, Tian R, Tennant RW, Todd SA, Tucker CJ, Van Houten B, Weis BK, Xuan S, Zarbl H; Members of the Toxicogenomics Research Consortium.

Nat Methods. 2005 May;2(5):351-6. Epub 2005 Apr 21. Erratum in: Nat Methods. 2005 Jun;2(6):477.

PMID:
15846362
39.

Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays.

Berchuck A, Iversen ES, Lancaster JM, Dressman HK, West M, Nevins JR, Marks JR.

Am J Obstet Gynecol. 2004 Apr;190(4):910-25.

PMID:
15118612
40.

Gene microarray analysis of human brain arteriovenous malformations.

Hashimoto T, Lawton MT, Wen G, Yang GY, Chaly T Jr, Stewart CL, Dressman HK, Barbaro NM, Marchuk DA, Young WL.

Neurosurgery. 2004 Feb;54(2):410-23; discussion 423-5.

PMID:
14744289
41.

Gene expression patterns that characterize advanced stage serous ovarian cancers.

Lancaster JM, Dressman HK, Whitaker RS, Havrilesky L, Gray J, Marks JR, Nevins JR, Berchuck A.

J Soc Gynecol Investig. 2004 Jan;11(1):51-9.

PMID:
14706684
42.
43.

Dissecting the fidelity of bacteriophage RB69 DNA polymerase: site-specific modulation of fidelity by polymerase accessory proteins.

Bebenek A, Carver GT, Dressman HK, Kadyrov FA, Haseman JK, Petrov V, Konigsberg WH, Karam JD, Drake JW.

Genetics. 2002 Nov;162(3):1003-18.

44.

Interacting fidelity defects in the replicative DNA polymerase of bacteriophage RB69.

Bebenek A, Dressman HK, Carver GT, Ng S, Petrov V, Yang G, Konigsberg WH, Karam JD, Drake JW.

J Biol Chem. 2001 Mar 30;276(13):10387-97. Epub 2000 Dec 22.

45.
46.

The roles of the bacteriophage T4 r genes in lysis inhibition and fine-structure genetics: a new perspective.

Paddison P, Abedon ST, Dressman HK, Gailbreath K, Tracy J, Mosser E, Neitzel J, Guttman B, Kutter E.

Genetics. 1998 Apr;148(4):1539-50.

47.

Retention of replication fidelity by a DNA polymerase functioning in a distantly related environment.

Dressman HK, Wang CC, Karam JD, Drake JW.

Proc Natl Acad Sci U S A. 1997 Jul 22;94(15):8042-6.

48.

Immunoglobulin gene rearrangement in multiple myeloma: limitations of Southern blot analysis.

Humphries JE, Dressman HK, Williams ME.

Hum Pathol. 1991 Oct;22(10):966-71.

PMID:
1842385

Supplemental Content

Loading ...
Support Center